KV Pharmaceutical
... that after KV Pharmaceutical received an FDA-sponsored monopoly to exclusively market a drug that had been already available for five decades, it raised its price from about US$15 to US$1,500?
... that after <b id="mwB_c"><a href="./KV_Pharmaceutical" id="mwB_g" rel="mw:WikiLink" title="KV Pharmaceutical">KV Pharmaceutical</a></b> received an <a href="./Food_and_Drug_Administration" id="mwB_k" rel="mw:WikiLink" title="Food and Drug Administration">FDA</a>-sponsored <a href="./Monopoly" id="mwB_o" rel="mw:WikiLink" title="Monopoly">monopoly</a> to <a href="./Orphan_drug" id="mwB_s" rel="mw:WikiLink" title="Orphan drug">exclusively market</a> <a class="mw-redirect" href="./17-Hydroxyprogesterone" id="mwB_w" rel="mw:WikiLink" title="17-Hydroxyprogesterone">a drug that had been already available for five decades</a>, it raised its price from about <a href="./United_States_dollar" id="mwB_0" rel="mw:WikiLink" title="United States dollar">US$</a>15 to US$1,500?